Company intelligence / Profile preview
ACHIM Biotherapeutics AB
Vällingby, Stockholm County, Sweden
- Ownership
- Private
- Development stage
- Other
01
Overview
ACHIM Biotherapeutics AB has been involved in clinical studies evaluating the efficacy of fecal microbiota transplantation for systemic sclerosis patients with gastrointestinal symptoms. Recent results indicate that this approach did not show significant benefit for these patients. No major safety concerns were reported.
- Therapeutic areas
- GastroenterologyRheumatology
- Modalities
- Microbiome-based therapeuticsFecal microbiota transplantation
- Industry
- Biotech
02
Drug pipeline
1 assetBeyond the preview
Go deeper on ACHIM Biotherapeutics AB.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on ACHIM Biotherapeutics AB.